Biomind Labs Inc.
BMNDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,226 | $7,757 | $54,300 | $23,846 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $648 | $629 | $671 |
| Enterprise Value | $1,226 | $8,405 | $54,929 | $24,516 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$2 | -$2 |
| % Margin | – | – | – | – |
| EBITDA | -$83 | -$98 | -$47 | -$16 |
| % Margin | – | – | – | – |
| Net Income | -$102 | -$117 | -$67 | $172 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.001 | -0.002 | -0.001 | 0.002 |
| % Growth | 13.3% | -66.7% | -140.9% | – |
| Operating Cash Flow | -$39 | $20 | $0 | -$103 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$39 | $20 | $0 | -$103 |